Biotechnology Industry Perspective on Drug Development

CLINICAL LEVERAGE STRATEGY IN ACCELERATING DRUG DEVELOPMENT 

Since the development in the 1970s of molecular tools enabling the production of proteins and peptides in sufficient quantities for therapeutic purposes, dedicated biotechnology companies have been examining, refining, and developing these technologies for commercialization. This 

Biotechnology and Biopharmaceuticals, by Rodney I Y. Ho and Milo Gibaldi ISBN 0-471-20690-3 Copyright 2003 by John Wiley Sons, Inc. 

Treatment, Prevention, or better disease management 

FigurG 3.1. The process of pharmaceutical drug discovery and development—an integrated science that draws on the collective knowledge and resources from both government and private sectors. Abbreviations NIH, National Institute of Health NSF, National Science Foundation PHS, Public Health Service. 

---